Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine 05/12/2022 OBSERVATIONAL unchanged 1,567.85 0 Rice Technologies for Cervical Cancer Screening and Diagnosis 05/12/2022 INTERVENTIONAL unchanged 1,567.85 0 Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp) 05/16/2022 INTERVENTIONAL unchanged 1,563.85 0 Early Life Exposures Among Children With Sickle Cell Disease 05/17/2022 INTERVENTIONAL unchanged 1,562.85 0 Abdominal Scar Improvement in Microsurgical Breast Reconstruction 05/17/2022 INTERVENTIONAL unchanged 1,562.85 0 Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer 05/17/2022 INTERVENTIONAL unchanged 1,562.85 0 Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial 05/18/2022 INTERVENTIONAL unchanged 1,561.85 0 Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section 05/19/2022 INTERVENTIONAL unchanged 1,560.85 0 Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage 05/19/2022 INTERVENTIONAL unchanged 1,560.85 0 Screening for Pregnancy Related Pelvic Girdle Pain 05/19/2022 INTERVENTIONAL unchanged 1,560.85 0 Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids 05/23/2022 OBSERVATIONAL unchanged 1,556.85 0 Domestic Violence Enhanced Perinatal Care Program in China 05/24/2022 INTERVENTIONAL unchanged 1,555.85 0 Early Detection of Gestational Diabetes Mellitus in Pregnancy 05/24/2022 INTERVENTIONAL unchanged 1,555.85 0 Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women 05/25/2022 OBSERVATIONAL unchanged 1,554.85 0 Identification of the Most Suitable Questionnaire to Assess the Sexual Function of Women Living in France After Colorectal Cancer Surgery 05/25/2022 INTERVENTIONAL unchanged 1,554.85 0 A Multi Center Study of Sexual Toxicities After Radiotherapy 05/27/2022 OBSERVATIONAL unchanged 1,552.85 0 Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer 05/27/2022 INTERVENTIONAL unchanged 1,552.85 0 Role of the Immune Environment in Response to Therapy in Breast Cancer 05/31/2022 OBSERVATIONAL unchanged 1,548.85 0 Galactagogue Use in Lactating Women With Low Milk Supply 06/01/2022 INTERVENTIONAL unchanged 1,547.85 0 Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer 06/01/2022 INTERVENTIONAL unchanged 1,547.85 0 Maternal Mindfulness: Depression and Postpartum Pain 06/01/2022 INTERVENTIONAL unchanged 1,547.85 0 Chemotherapy Supported by Autologous Hematopoietic Stem Cells 06/02/2022 INTERVENTIONAL unchanged 1,546.85 0 Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients 06/02/2022 INTERVENTIONAL unchanged 1,546.85 0 Mental Stress Reactivity in Women With CMD 06/02/2022 INTERVENTIONAL unchanged 1,546.85 0 Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women 06/03/2022 INTERVENTIONAL unchanged 1,545.85 0 Mediterranean Diet on Pregnancy and Foetus Development 06/03/2022 OBSERVATIONAL unchanged 1,545.85 0 Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment 06/03/2022 OBSERVATIONAL unchanged 1,545.85 0 Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment 06/06/2022 OBSERVATIONAL unchanged 1,542.85 0 To Improve Depressive Symptoms Using a Web-App 06/06/2022 INTERVENTIONAL unchanged 1,542.85 0 Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer 06/06/2022 INTERVENTIONAL unchanged 1,542.85 0 Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer 06/06/2022 INTERVENTIONAL unchanged 1,542.85 0 PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer 06/07/2022 INTERVENTIONAL unchanged 1,541.85 0 Targeting Inflammation for Endometrial Cancer Prevention 06/07/2022 OBSERVATIONAL unchanged 1,541.85 0 Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) 06/07/2022 INTERVENTIONAL unchanged 1,541.85 0 Moving Forward Together 4 06/08/2022 INTERVENTIONAL unchanged 1,540.85 0 LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients 06/08/2022 OBSERVATIONAL unchanged 1,540.85 0 A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer 06/09/2022 INTERVENTIONAL unchanged 1,539.85 0 Clinic-based HIV Identification and Prevention Project Using Electronic Resources 06/09/2022 INTERVENTIONAL unchanged 1,539.85 0 Evolutive and Functional Bases of Menstruation in Women - 2 06/09/2022 INTERVENTIONAL unchanged 1,539.85 0 Ultrasound-guided Manual Vacuum Aspiration (USG-MVA) 06/10/2022 OBSERVATIONAL unchanged 1,538.85 0 Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa 06/10/2022 INTERVENTIONAL unchanged 1,538.85 0 Impact of Sleep Disturbance on Cognition and Quality of Life in Breast Cancer 06/10/2022 INTERVENTIONAL unchanged 1,538.85 0 Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management 06/13/2022 INTERVENTIONAL unchanged 1,535.85 0 DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy 06/13/2022 INTERVENTIONAL unchanged 1,535.85 0 Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) 06/13/2022 INTERVENTIONAL unchanged 1,535.85 0 Life Study: Lifestyle Intervention in Fibroid Elimination 06/13/2022 INTERVENTIONAL unchanged 1,535.85 0 Lifestyle Behaviours of Women Newly Diagnosed With Heart Failure 06/14/2022 OBSERVATIONAL unchanged 1,534.85 0 Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer 06/14/2022 INTERVENTIONAL unchanged 1,534.85 0 A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2) 06/14/2022 INTERVENTIONAL unchanged 1,534.85 0 Evaluation of Lifestyle Modification on Cardiovascular Risk 06/14/2022 INTERVENTIONAL unchanged 1,534.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology